These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1097150)

  • 21. Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
    Antonaccio MJ; Coté D; Cavaliere T
    Clin Exp Pharmacol Physiol; 1976; 3(3):199-206. PubMed ID: 975616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function studies with cadralazine in conscious dogs: a comparison with hydralazine.
    Ferni G; Bonardi G; Lombroso M; Semeraro C; Dorigotti L
    Pharmacol Res; 1989; 21(2):211-22. PubMed ID: 2664751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension.
    Wilner KD; Ziegler MG
    Am J Cardiol; 1987 May; 59(14):82G-86G. PubMed ID: 2884858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.
    Igreja B; Wright LC; Soares-da-Silva P
    J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unimpaired beta adrenergic responses during prazosin administration.
    Buzzeo LA; Steele JM; Lowenstein J
    J Pharmacol Exp Ther; 1979 Nov; 211(2):345-9. PubMed ID: 228024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 29. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension.
    Almeida L; Nunes T; Costa R; Rocha JF; Vaz-da-Silva M; Soares-da-Silva P
    Clin Ther; 2013 Dec; 35(12):1983-96. PubMed ID: 24296323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB; Gonik B; Dorman KF
    Surg Gynecol Obstet; 1985 Sep; 161(3):240-4. PubMed ID: 4035539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-course changes in blood pressure, urinary excretion of norepinephrine and dopamine after administration of fusaric acid in a single dose in elderly hypertensive patients.
    Terasawa F; Hidaka H
    Jpn Circ J; 1976 Jul; 40(7):785-91. PubMed ID: 987254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR; Saxena PR
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of cerebrovascular CO2 reactivity by inhibition of dopamine beta-hydroxylase.
    Oishi M; Gotoh F; Toyoda M; Seki T; Takeoka T; Takagi S; Niimi T
    Stroke; 1979; 10(4):407-11. PubMed ID: 41344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of antihypertensive medication on the control of the cardiovascular system during halothane anaesthesia in rats.
    Kaukinen S; Ylitalo P
    Acta Anaesthesiol Scand; 1978; 22(1):64-75. PubMed ID: 636807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats.
    Zhang W; Sun X; Zhao X; Thorén P; Hedner T
    Acta Physiol Scand; 1997 Sep; 161(1):7-14. PubMed ID: 9381952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive drugs and catecholamine metabolism: effects of reserpine and hydralazine on tyrosine hydroxylase activity and norepinephrine concentrations in the spontaneously hypertensive rat.
    Kohler C; Berkowitz BA; Spector S
    J Pharmacol Exp Ther; 1975 May; 193(2):443-51. PubMed ID: 238020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.